Skip to main content
Acta Crystallographica Section E: Structure Reports Online logoLink to Acta Crystallographica Section E: Structure Reports Online
. 2011 Mar 9;67(Pt 4):o806–o807. doi: 10.1107/S1600536811008105

2-Methyl-5,6-dinitro­benzimidazolium chloride

Sebla Dinçer a, Gonca Gönülalan a, Barış Tercan b, Tuncer Hökelek c,*
PMCID: PMC3100037  PMID: 21754094

Abstract

In the title compound, C8H7N4O4 +·Cl−, the cation possesses twofold symmetry, with the twofold axis bis­ecting the 2-methyl-5,6-dinitro­benzimidazolium cation. The methyl H atoms are disordered about this twofold axis and were assigned equal half-occupancies. The chloride anion also lies on a twofold axis. In the crystal, N—H⋯Cl and C—H⋯O hydrogen bonds link the ions to form a three-dimensional network.

Related literature

For literature on the anti­tumour, anthelmintic, anti­bacterial, virucidal and fungicidal properties of benzimidazole derivatives, see: Refaat (2010 ▶); Laryea et al. (2010 ▶); Horton et al. (2003 ▶); Spasov et al. (1999 ▶); Soula & Luu-Duc (1986 ▶). For literature on the coordination and corrosion inhibitor abilities of the benzimidazoles, see: Kuznetsov & Kaza­nsky (2008 ▶); Subramanyam & Mayanna (1985 ▶). For literature on the use of benzimidazole derivatives as photographic materials and dyes, see: Hoffmann et al. (2011 ▶); Alamgir et al. (2007 ▶). For a related structure, see: Hökelek et al. (2002 ▶).graphic file with name e-67-0o806-scheme1.jpg

Experimental

Crystal data

  • C8H7N4O4 +·Cl−

  • M r = 258.63

  • Orthorhombic, Inline graphic

  • a = 4.9453 (1) Å

  • b = 20.4691 (4) Å

  • c = 10.4543 (3) Å

  • V = 1058.25 (4) Å3

  • Z = 4

  • Mo Kα radiation

  • μ = 0.37 mm−1

  • T = 100 K

  • 0.46 × 0.40 × 0.20 mm

Data collection

  • Bruker Kappa APEXII CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2001 ▶) T min = 0.848, T max = 0.929

  • 3043 measured reflections

  • 1302 independent reflections

  • 1264 reflections with I > 2σ(I)

  • R int = 0.016

Refinement

  • R[F 2 > 2σ(F 2)] = 0.024

  • wR(F 2) = 0.062

  • S = 1.11

  • 1302 reflections

  • 83 parameters

  • H atoms treated by a mixture of independent and constrained refinement

  • Δρmax = 0.27 e Å−3

  • Δρmin = −0.16 e Å−3

  • Absolute structure: Flack (1983 ▶), 517 Friedel pairs

  • Flack parameter: 0.10 (6)

Data collection: APEX2 (Bruker, 2007 ▶); cell refinement: SAINT (Bruker, 2007 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997 ▶) and Mercury (Macrae et al., 2006 ▶); software used to prepare material for publication: WinGX (Farrugia, 1999 ▶).

Supplementary Material

Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536811008105/su2261sup1.cif

e-67-0o806-sup1.cif (13.8KB, cif)

Structure factors: contains datablocks I. DOI: 10.1107/S1600536811008105/su2261Isup2.hkl

e-67-0o806-Isup2.hkl (63.1KB, hkl)

Additional supplementary materials: crystallographic information; 3D view; checkCIF report

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A D⋯A D—H⋯A
N2—H2A⋯Cl1 0.86 (2) 2.15 (2) 3.008 (1) 172.5 (18)
C2—H2⋯O1i 0.93 2.51 3.339 (2) 150

Symmetry code: (i) Inline graphic.

Acknowledgments

The authors are indebted to Anadolu University and the Medicinal Plants and Medicine Research Centre of Anadolu University, Eskişehir, Turkey, for the use of the X-ray diffractometer.

supplementary crystallographic information

Comment

Benzimidazole derivatives are privileged structures in pharmaceutical chemistry because of their biological activities and clinical applications. They exhibit antitumor, anthelmintic, antibacterial, virucidal and fungucidal properties (Refaat, 2010; Laryea et al., 2010; Horton et al., 2003; Spasov et al., 1999; Soula & Luu-Duc, 1986). In addition to their biological activities, a review of the literature reveals that there are numerous studies including the coordination and corrosion inhibitor abilities of benzimidazoles (Kuznetsov & Kazansky, 2008; Subramanyam & Mayanna, 1985). Some of these derivatives, particularly nitro derivatives, are used as photographic materials in photography and on the other hand, the development of the chemistry of the benzimidazole dyes has been remarkable (Hoffmann et al., 2011; Alamgir et al., 2007). As a part of our ongoing investigations of benzimidazole derivatives, the title compound was synthesized and its crystal structure is reported herein.

The asymmetric unit of the title compound, (Fig. 1), contains one half of each component. It consists of an imidazole ring with the one CH3 and two NO2 groups bonded at positions 2, 5 and 6, respectively, and one chloride anion. Both the 2-methyl-5,6-dinitrobenzimidazolium moiety and the chloride anion lie on twofold axes. The methyl H atoms are disordered about the twofold axis with equal half occupancies.

In the crystal of the title compound N—H···Cl hydrogen bonds link the cations to form zigzag chains propagating in [001]. There are also C—H···O hydrogen bonds linking these chains to form a three-dimensional network (Table 1 and Fig. 2).

The crystal structure of a similar benzimidazole derivative, (C7H4N4O4).H2O, has been reported (Hökelek et al., 2002).

Experimental

For the preparation of the title compound a solution of 2-methyl-5-nitro- benzimidazole (3.0 g) in sulphuric acid (3.0 ml) was treated with nitric acid (6.0 ml) and refluxed for 3 h, then poured onto ice. The precipitate was filtered off and washed with cold water. Hydrogen chloride was passed into a suspension of the crude dinitro product in warm water. After cooling, the precipitate was filtered and crystallized from ethanol to give yellow block-like crystals of the the title compound (m.p. 507-512 K).

Refinement

Atom H2A (for the NH group) was located in a difference Fourier map and was freely refined. The C-bound H-atoms were positioned geometrically with C—H = 0.93 and 0.96 Å, for aromatic and methyl H-atoms, respectively, and constrained to ride on their parent atoms, with Uiso(H) = k × Ueq(C), where k = 1.5 for methyl H-atoms and k = 1.2 for all other H-atoms.

Figures

Fig. 1.

Fig. 1.

The molecular structure of the title compound with the displacement ellipsoids drawn at the 50% probability level. The N-H···Cl hydrogen bond is shown as a dashed line.

Fig. 2.

Fig. 2.

A view along the a-axis of the crystal packing of the title compound. Hydrogen bonds are shown as dashed lines [H-atoms not involved in hydrogen bonding have been omitted for clarity].

Crystal data

C8H7N4O4+·Cl− F(000) = 528
Mr = 258.63 Dx = 1.623 Mg m−3
Orthorhombic, C2221 Mo Kα radiation, λ = 0.71073 Å
Hall symbol: C 2c 2 Cell parameters from 2425 reflections
a = 4.9453 (1) Å θ = 2.8–28.2°
b = 20.4691 (4) Å µ = 0.37 mm−1
c = 10.4543 (3) Å T = 100 K
V = 1058.25 (4) Å3 Block, yellow
Z = 4 0.46 × 0.40 × 0.20 mm

Data collection

Bruker Kappa APEXII CCD area-detector diffractometer 1302 independent reflections
Radiation source: fine-focus sealed tube 1264 reflections with I > 2σ(I)
graphite Rint = 0.016
φ and ω scans θmax = 28.3°, θmin = 2.0°
Absorption correction: multi-scan (SADABS; Bruker, 2001) h = −6→6
Tmin = 0.848, Tmax = 0.929 k = −20→26
3043 measured reflections l = −13→13

Refinement

Refinement on F2 Secondary atom site location: difference Fourier map
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.024 H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.062 w = 1/[σ2(Fo2) + (0.0335P)2 + 0.4282P] where P = (Fo2 + 2Fc2)/3
S = 1.11 (Δ/σ)max < 0.001
1302 reflections Δρmax = 0.27 e Å−3
83 parameters Δρmin = −0.16 e Å−3
0 restraints Absolute structure: Flack (1983), 517 Friedel pairs
Primary atom site location: structure-invariant direct methods Flack parameter: 0.10 (6)

Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq Occ. (<1)
Cl1 0.38240 (8) 0.0000 0.5000 0.02165 (12)
O1 0.9799 (2) 0.31462 (5) 0.62135 (10) 0.0235 (2)
O2 0.5726 (2) 0.27552 (5) 0.60594 (10) 0.0234 (2)
N1 0.8093 (2) 0.27227 (6) 0.64031 (11) 0.0174 (2)
N2 0.8329 (2) 0.03251 (5) 0.68250 (10) 0.0133 (2)
H2A 0.712 (4) 0.0200 (10) 0.628 (2) 0.035 (6)*
C1 0.8975 (3) 0.21173 (6) 0.70323 (11) 0.0143 (2)
C2 0.7865 (3) 0.15455 (7) 0.65679 (12) 0.0146 (3)
H2 0.6486 0.1545 0.5963 0.018*
C3 0.8933 (3) 0.09724 (6) 0.70596 (11) 0.0124 (2)
C4 1.0000 −0.00475 (10) 0.7500 0.0143 (3)
C5 1.0000 −0.07722 (10) 0.7500 0.0207 (4)
H5A 0.8609 −0.0929 0.6937 0.031* 0.50
H5B 0.9666 −0.0929 0.8351 0.031* 0.50
H5C 1.1726 −0.0929 0.7211 0.031* 0.50

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
Cl1 0.01317 (19) 0.0379 (3) 0.01385 (18) 0.000 0.000 −0.00422 (19)
O1 0.0284 (5) 0.0159 (5) 0.0261 (5) −0.0007 (4) 0.0058 (4) 0.0042 (4)
O2 0.0231 (5) 0.0213 (5) 0.0259 (5) 0.0069 (4) −0.0046 (4) 0.0017 (4)
N1 0.0222 (6) 0.0145 (5) 0.0156 (5) 0.0036 (5) 0.0015 (4) 0.0010 (4)
N2 0.0137 (5) 0.0129 (5) 0.0133 (5) −0.0011 (4) 0.0006 (4) −0.0010 (4)
C1 0.0145 (6) 0.0127 (6) 0.0157 (5) 0.0026 (5) 0.0030 (5) 0.0019 (4)
C2 0.0133 (5) 0.0169 (6) 0.0137 (5) 0.0015 (5) 0.0000 (4) 0.0009 (5)
C3 0.0129 (5) 0.0125 (6) 0.0117 (5) −0.0009 (5) 0.0026 (5) −0.0007 (4)
C4 0.0145 (7) 0.0154 (9) 0.0131 (7) 0.000 0.0035 (6) 0.000
C5 0.0250 (10) 0.0110 (9) 0.0261 (10) 0.000 0.0025 (8) 0.000

Geometric parameters (Å, °)

N1—O1 1.2259 (16) C2—H2 0.9300
N1—O2 1.2260 (16) C3—C3i 1.401 (3)
N1—C1 1.4692 (17) C4—N2 1.3275 (16)
N2—C3 1.3801 (16) C4—N2i 1.3275 (16)
N2—H2A 0.86 (2) C4—C5 1.483 (3)
C1—C1i 1.409 (3) C5—H5A 0.9600
C2—C1 1.3808 (18) C5—H5B 0.9600
C2—C3 1.3855 (18) C5—H5C 0.9600
O1—N1—O2 124.84 (12) N2—C3—C2 131.66 (12)
O1—N1—C1 117.67 (11) N2—C3—C3i 106.24 (7)
O2—N1—C1 117.41 (11) C2—C3—C3i 122.08 (8)
C3—N2—H2A 123.5 (14) N2i—C4—N2 109.87 (17)
C4—N2—C3 108.82 (12) N2i—C4—C5 125.07 (9)
C4—N2—H2A 127.6 (14) N2—C4—C5 125.07 (9)
C1i—C1—N1 121.63 (7) C4—C5—H5A 109.5
C2—C1—N1 116.07 (11) C4—C5—H5B 109.5
C2—C1—C1i 122.02 (8) C4—C5—H5C 109.5
C1—C2—C3 115.83 (12) H5A—C5—H5B 109.5
C1—C2—H2 122.1 H5A—C5—H5C 109.5
C3—C2—H2 122.1 H5B—C5—H5C 109.5
O1—N1—C1—C1i 33.8 (2) C3—C2—C1—N1 172.73 (11)
O1—N1—C1—C2 −140.30 (13) C3—C2—C1—C1i −1.3 (2)
O2—N1—C1—C1i −149.18 (15) C1—C2—C3—N2 179.82 (13)
O2—N1—C1—C2 36.76 (17) C1—C2—C3—C3i −2.1 (2)
C4—N2—C3—C2 177.52 (13) N2i—C4—N2—C3 0.32 (6)
C4—N2—C3—C3i −0.81 (16) C5—C4—N2—C3 −179.68 (6)

Symmetry codes: (i) −x+2, y, −z+3/2.

Hydrogen-bond geometry (Å, °)

D—H···A D—H H···A D···A D—H···A
N2—H2A···Cl1 0.86 (2) 2.15 (2) 3.008 (1) 172.5 (18)
C2—H2···O1ii 0.93 2.51 3.339 (2) 150

Symmetry codes: (ii) x−1/2, −y+1/2, −z+1.

Footnotes

Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SU2261).

References

  1. Alamgir, M., Black, D. S. C. & Kumar, N. (2007). Top. Heterocycl. Chem. 9, 87–118.
  2. Bruker (2001). SADABS Bruker AXS Inc., Madison, Wisconsin, USA.
  3. Bruker (2007). APEX2 and SAINT Bruker AXS Inc., Madison, Wisconsin, USA.
  4. Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
  5. Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837–838.
  6. Flack, H. D. (1983). Acta Cryst. A39, 876–881.
  7. Hoffmann, H. S., Stefani, V., Benvenutti, E. V., Costa, T. M. H. & Gallas, M. R. (2011). Mater. Chem. Phys. 126, 97–101.
  8. Hökelek, T., Dinçer, S. & Kılıç, E. (2002). Cryst. Res. Technol. 37, 1138–1142.
  9. Horton, D. A., Bourne, G. T. & Smythe, M. L. (2003). Chem. Rev. 103, 893–930. [DOI] [PubMed]
  10. Kuznetsov, Y. I. & Kazansky, L. P. (2008). Russ. Chem. Rev. 77, 219–232.
  11. Laryea, D., Gullbo, J., Isakssoon, A., Larsson, R. & Nygren, P. (2010). Anti-Cancer Drugs, 21, 33–42. [DOI] [PubMed]
  12. Macrae, C. F., Edgington, P. R., McCabe, P., Pidcock, E., Shields, G. P., Taylor, R., Towler, M. & van de Streek, J. (2006). J. Appl. Cryst. 39, 453–457.
  13. Refaat, H. M. (2010). Eur. J. Med. Chem. 45, 2949–2956. [DOI] [PubMed]
  14. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  15. Soula, C. & Luu-Duc, C. (1986). Lyon Pharm. 37, 297–302.
  16. Spasov, A. A., Yozhitsa, I. N., Bugaeva, L. I. & Anisimova, V. A. (1999). Pharm. Chem. J. 33, 232–243.
  17. Subramanyam, N. C. & Mayanna, S. M. (1985). Corros. Sci. 25, 163–169.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536811008105/su2261sup1.cif

e-67-0o806-sup1.cif (13.8KB, cif)

Structure factors: contains datablocks I. DOI: 10.1107/S1600536811008105/su2261Isup2.hkl

e-67-0o806-Isup2.hkl (63.1KB, hkl)

Additional supplementary materials: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Structure Reports Online are provided here courtesy of International Union of Crystallography

RESOURCES